- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.30 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x X49: (4S)-1-{[(4S)-2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl}-4-(4,4,4-trifluorobutyl)pyrrolidin-2-one(Non-covalent)
- 1 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x PS1: 1,2-DIDECANOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mittal, A. et al., Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants. Nat.Struct.Mol.Biol. (2024)
- Release Date
- 2024-05-22
- Peptides
- Synaptic vesicle glycoprotein 2A: A
Nanobody: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.